Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns

Diabetes

Volumn 55, Issue 9, 2006, Pages 2534-2540

  Bonnycastle, Lori L ^a   Willer, Cristen J ^b   Conneely, Karen N ^b   Jackson, Anne U ^b   Burrill, Cecily P ^a   Watanabe, Richard M ^c   Chines, Peter S ^a   Narisu, Narisu ^a   Scott, Laura J ^b   Enloe, Sareena T ^a   Swift, Amy J ^a   Duren, William L ^b   Stringham, Heather M ^b   Erdos, Michael R ^a   Riebow, Nancy L ^a   Buchanan, Thomas A ^c   Valle, Timo T ^d   Tuomilehto, Jaakko ^d,e,f   Bergman, Richard N ^c   Mohlke, Karen L ^g   Boehnke, Michael ^b   Collins, Francis S ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Fusion, Finland U.S. Investigation of NIDDM Genetics Study; LD, linkage disequilibrium; MODY, maturity onset diabetes of the young; SNP, single nucleotide polymorphism

Indexed keywords

ARTICLE; CONTROLLED STUDY; FINLAND; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; CLINICAL TRIAL; FEMALE; GENETICS; MALE; MIDDLE AGED; MULTICENTER STUDY;

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; NEUROD1 PROTEIN, HUMAN; TCF1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANS-ACTIVATORS;

EID: 33750596924     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0178     Document Type: Article

References (50)

1. Lazar MA: How obesity causes diabetes: not a tall tale. Science 307:373-375, 2005
2. Fajans SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971-980, 2001
3. Servitja JM, Ferrer J: Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 47:597-613, 2004
4. Yamagata K: Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturityonset diabetes of the young (MODY). Endocr J 50:491-499, 2003
5. Malecki MT: Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 68 (Suppl. 1):S10-S21, 2005
6. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883, 1999
7. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849, 2004
8. Parikh H, Groop L: Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 5:151-176, 2004
9. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B: The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84:1077-1082, 1999
10. Hani EH, Stoffers DA, Chevre JC, Durand E, Stanojevic V, Dina C, Habener JF, Froguel P: Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 104:R41-R48, 1999
11. Macfarlane WM, Frayling TM, Ellard S, Evans JC, Allen LI, Bulman MP, Ayres S, Shepherd M, Clark P, Millward A, Demaine A, Wilkin T, Docherty K, Hattersley AT: Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 104:R33-R39, 1999
12. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS: Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328, 1999
13. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1:E20, 2003
14. Bagwell AM, Bento JL, Mychaleckyj JC, Freedman BI, Langefeld CD, Bowden DW: Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 54:1185-1190, 2005
15. Mohlke KL, Boehnke M: The role of HNF4A variants in the risk of type 2 diabetes. Curr Diab Rep 5:149-156, 2005
16. Muller YL, Infante AM, Hanson RL, Love-Gregory L, Knowler W, Bogardus C, Baier LJ: Variants in hepatocyte nuclear factor 4 {alpha} are modestly associated with type 2 diabetes in Pima Indians. Diabetes 54:3035-3039, 2005
17. Karim MA, Wang X, Hale TC, Elbein SC: Insulin promoter factor 1 variation is associated with type 2 diabetes in African Americans. BMC Med Genet 6:37, 2005
18. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, Jackson AU, Deloukas P, Hunt S, Stavrides G, Chines PS, Erdos MR, Narisu N, Conneely KN, Li C, Fingerlin TE, Dhanjal SK, Valle TT, Bergman RN, Tuomilehto J, Watanabe RM, Boehnke M, Collins FS: Genetic variation near the hepatocyte nuclear factor-4 {alpha} gene predicts susceptibility to type 2 diabetes. Diabetes 53:1141-1149, 2004
19. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, Permutt MA: A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4{alpha} gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53:1134-1140, 2004
20. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, McCarthy MI, Love-Gregory LD, Permutt MA, Hattersley AT, Frayling TM: Common variants of the hepatocyte nuclear factor-4{alpha} P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 53:3002-3006, 2004
21. Damcott CM, Hoppman N, Ott SH, Reinhart LJ, Wang J, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR: Polymorphisms in both promoters of hepatocyte nuclear factor 4-{alpha} are associated with type 2 diabetes in the Amish. Diabetes 53:3337-3341, 2004
22. Hansen SK, Rose CS, Glumer C, Drivsholm T, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T: Variation near the hepatocyte nuclear factor (HNF)-4{alpha} gene associates with type 2 diabetes in the Danish population. Diabetologia 48:452-458, 2005
23. Winckler W, Graham RR, de Bakker PI, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Groop L, Altshuler D: Association testing of variants in the hepatocyte nuclear factor 4{alpha} gene with risk of type 2 diabetes in 7,883 people. Diabetes 54:886-892, 2005
24. Vaxillaire M, Dina C, Lobbens S, Dechaume A, Vasseur-Delannoy V, Helbecque N, Charpentier G, Froguel P: Effect of common polymorphisms in the HNF4alpha promoter on susceptibility to type 2 diabetes in the French Caucasian population. Diabetologia 48:440-444, 2005
25. Consortium TIH: A haplotype map of the human genome. Nature 437:1299-1320, 2005
26. Valle T, Tuomilehto J, Bergman RN, Ghosh S, Hauser ER, Eriksson J, Nylund SJ, Kohtamaki K, Toivanen L, Vidgren G, Tuomilehto-Wolf E, Ehnholm C, Blaschak J, Langefeld CD, Watanabe RM, Magnuson V, Ally DS, Hagopian WA, Ross E, Buchanan TA, Collins F, Boehnke M: Mapping genes for NIDDM: design of the Finland-United States Investigation of NIDDM Genetics (FUSION) study. Diabetes Care 21:949-958, 1998
27. Silander K, Scott LJ, Valle TT, Mohlke KL, Stringham HM, Wiles KR, Duren WL, Doheny KF, Pugh EW, Chines P, Narisu N, White PP, Fingerlin TE, Jackson AU, Li C, Ghosh S, Magnuson VL, Colby K, Erdos MR, Hill JE, Hollstein P, Humphreys KM, Kasad RA, Lambert J, Lazaridis KN, Lin G, Morales-Mena A, Patzkowski K, Pfahl C, Porter R, Rha D, Segal L, Suh YD, Tovar J, Unni A, Welch C, Douglas JA, Epstein MP, Hauser ER, Hagopian W, Buchanan TA, Watanabe RM, Bergman RN, Tuomilehto J, Collins FS, Boehnke M: A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes 53:821-829, 2004
28. Saaristo T, Peltonen M, Lindström J, Saarikoski L, Eriksson J, Tuomilehto J: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diabetes Vasc Dis Res 2:67-72, 2005
29. Winckler W, Burtt NP, Holmkvist J, Cervin C, de Bakker PI, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Altshuler D, Groop L: Association of common variation in the HNF1 {alpha} gene region with risk of type 2 diabetes. Diabetes 54:2336-2342, 2005
30. Skol AD, Scott LJ, Abecasis GR, Boehnke M: Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209-213, 2006
31. Abecasis GR, Cookson WO: GOLD: graphical overview of linkage disequilibrium. Bioinformatics 16:182-183, 2000
32. Lin DY: An efficient Monte Carlo approach to assessing statistical significance in genomic studies. Bioinformatics 21:781-787, 2005
33. Seaman SR, Muller-Myhsok B: Rapid simulation of P values for product methods and multiple-testing adjustment in association studies. Am J Hum Genet 76:399-408, 2005
34. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, 2005
35. Becker T, Knapp M: A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 75:561-570, 2004
36. Marz W, Nauck M, Hoffmann MM, Nagel D, Boehm BO, Koenig W, Rothenbacher D, Winkelmann BR: G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 109:2844-2849, 2004
37. Ye L, Xu Y, Zhu Y, Fan Y, Deng H, Zhang J: Association of polymorphism in neurogenic differentiation factor 1 gene with type 2 diabetes. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19:484-487, 2002
38. Kavvoura FK, Ioannidis JP: Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis. Hum Genet 116:192-199, 2005
39. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, McCarthy MI, Hattersley AT, Frayling TM: A large-scale association analysis of common variation of the HNF1{alpha} gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54:2487-2491, 2005
40. Kulkarni RN, Kahn CR: Molecular biology: HNFs: linking the liver and pancreatic islets in diabetes. Science 303:1311-1312, 2004
41. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT: β-Cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 (Suppl. 1):S94-S100, 2001
42. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83, 1997
43. Boyle MP: Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 9:498-503, 2003
44. Kruger R: Genes in familial parkinsonism and their role in sporadic Parkinson's disease. J Neurol 251 (Suppl. 6):VI/2-6, 2004
45. Skipper L, Li Y, Bonnard C, Pavanni R, Yih Y, Chua E, Sung WK, Tan L, Wong MC, Tan EK, Liu J: Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. 14:3549-3556, 2005
46. Dalgleish R: The human type I collagen mutation database. Nucleic Acid Res 25:181-187, 1997
47. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH: Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 14:203-205, 1996
48. Peris P, Alvarez L, Oriola J, Guanabens N, Monegal A, de Osaba MJ, Jo J, Pons F, Ballesta AM, Munoz-Gomez J: Collagen type Ialpha1 gene polymorphism in idiopathic osteoporosis in men. Rheumatology (Oxford) 39:1222-1225, 2000
49. Hegele RA: Small genetic effects in complex diseases: a review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Clin Biochem 30:183-188, 1997
50. Knight JC: Regulatory polymorphisms underlying complex disease traits. J Mol Med 83:97-109, 2005